AGMB AgomAb Therapeutics NV

NASDAQ
$11.41

AgomAb Therapeutics NV (AGMB) is expected to report earnings on August 6, 2026, after the market close. The consensus earnings estimate is a loss of $0.39 per share.

Earnings Date
2nd Quarter, Jun 2026
Aug 6
Thursday · After Close
Earnings Whisper
-
vs ($0.39)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.